AMO Pharma Reports Positive Data from Investigator-Led TIDE Study of AMO-02 in Autism Spectrum Disorder - PR Newswire (press release)

Submitted by Anonymous (not verified) on Mon, 10/29/2018 - 15:19

AMO Pharma Reports Positive Data from Investigator-Led TIDE Study of AMO-02 in Autism Spectrum DisorderPR Newswire (press release)LONDON and DURHAM, N.C., Oct. 29, 2018 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited or no treatment options, recently ...and more »